ArticleClinical and translational science2024

Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes.

Xiaojie Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.